Gurusamy, K.S., M. Nagendran and B.R. Davidson, 2013. Early versus delayed laparoscopic cholecystectomy for acute gallstone pancreatitis. Cochrane. Database. Syst. Rev., Vol. 2, 10326. 10.1002/14651858.CD010326.pub2.
Testoni, P.A., 2014. Acute recurrent pancreatitis: Etiopathogenesis, diagnosis and treatment. World. J. Gastroenterol. 20: 16891-16901.
Peery, A.F., S.D. Crockett, C.C. Murphy, J.L. Lund and E.S. Dellon et al., 2019. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the united states: Update 2018. Gastroenterology., 156: 254-272.
Kota, S.K., S.V.S. Krishna, S. Lakhtakia and K.D. Modi, 2017. Metabolic pancreatitis: Etiopathogenesis and management. Indian. J. Endocrinol. Metab., 17: 799-705.
Chiu, H.Yi, T.S. Wang, P.H. Chen, S.H. Hsu, Y.C. Tsai and T.F. Tsai, 2018. Psoriasis in taiwan: From epidemiology to new treatments. Dermatol. Sin., 36: 115-123.
Ghatnekar, O., A. Ljungberg, L.E. Wirestrand and A. Svensson, 2012. Costs and quality of life for psoriatic patients at different degrees of severity in southern Sweden: A cross-sectional study. Eur. J. Dermatol., 22: 238-245.
Siegel, R.L., K.D. Miller and A.Jemal, 2019. Cancer statistics, 2019. CA. Cancer. J. Clin., 69: 7-34.
Wu, M., J. Guo, L. Guo and Q. Zuo, 2016. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. Tumour. Biol., 37: 12525-12533.
Haruki, K., H. Shiba, Y. Shirai, T. Horiuchi and R. Iwase et al., 2016. The C-reactive protein to albumin ratio predicts long-term outcomes in patients with pancreatic cancer after pancreatic resection. World. J. Surg., 40: 2254-2260.
Lelubre, C., S. Anselin, K.Z. Boudjeltia, P. Biston and M. Piagnerelli, 2013. Interpretation of c-reactive protein concentrations in critically ill patients. Biomed. Res. Int., Vol. 2013, 124021. 10.1155/2013/124021.
Goh, S.L., R.P. de Silva, K. Dhital and R.M. Gett, 2015. Is low serum albumin associated with postoperative complications in patients undergoing oesophagectomy for oesophageal malignancies? Interact. Cardiovasc. Thorac. Surg., 20: 107-103.
Martin, D., F. Rödel, P. Balermpas, R. Winkelmann, E. Fokas and C. Rödel, 2019. C-reactive protein-to-albumin ratio as prognostic marker for anal squamous cell carcinoma treated with chemoradiotherapy. Font. Oncol., Vol. 9. 10.3389/fonc.2019.01200.
Han, S., J. Ye, R. Liu, W. Chen and Z. Feng, 2019. The role of CRP or albumin with ranson scale in predicting severe acute pancreatitis mortality risk. Int. J. Clin. Exp. Med., 12: 10531-10536.
Tanoue, K., S. Tamura, H. Kusaba, Y. Shinohara and M. Ito et al., 2021. Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab. Sci. Rep., Vol. 11, 2741. 10.1038/s41598-021-82448-1.
Kaplan, M., I. Ates, M.Y. Akpinar, M. Yuksel and U.B. Kuzu et al., 2017. Predictive value of C-reactive protein/albumin ratio in acute pancreatitis. Hepatobiliary Pancreatic Dis. Int., 16: 424-430.
Wang, F., P. Li and F.S. Li, 2019. Prognostic role of c-reactive protein to albumin ratio in colorectal cancer. Medicine, Vol. 98. 10.1097/md.0000000000016064.
Kim, M.H., J.Y. Ahn, J.E. Song, H. Choi and H.W. Ann et al., 2015. The C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PLOS ONE, Vol. 10. 10.1371/journal.pone.0132109.